AfroMedicine, a New Delhi-based company, has introduced AfroMedicine, an Afromedicine brand.

The company claims to be the first Afro Medicine brand to offer the Afro brand to the mainstream Indian market.

The Afro Medicine brand will be available in India starting April 2019, and will be manufactured by the company in Bengaluru.

Afro medicine is a blend of herbs and spices that have a wide range of effects and benefits, such as helping to reduce the risk of heart disease, cancer and obesity.

Afros medicines have been used by millions of Indians in the last decade.

It was also a priority for the Indian government to introduce Afro medicines in the country in 2015, as part of its efforts to curb obesity.

The country’s government also plans to introduce a nationwide programme to make the sale of Afros easier.

Afropillare is a term used to describe a combination of herbal medicines with medicinal or pharmaceutical ingredients, which includes a mix of herbs with pharmaceuticals.

The products are currently being marketed under the Afropile brand, with the Afronomix brand launching in July 2019.

Afronomex, the other brand, is currently available only in India.

The AfronomiX brand has been launched in Brazil, while Afro Medicine will be launched in several other countries.

The first Afros medicine is named AfroMix, which is made with two of the world’s most popular Afro herbs, Fennel and Fenné, which are popular in South Asia and Africa.

Afrodex is a combination Afro medication, which has been shown to be effective in treating some health problems, such a chronic condition called osteoarthritis, in the UK.

The other Afros brand, AfroOmni, is a mixture of Afrodin, an anti-inflammatory drug, and Fecalibre, which may help to reduce bloating and diarrhea, among other ailments.

Afrotrex, a combination medicine that includes Fecin, will be sold in the US, while the Afrotrix brand, which also includes Fennell, is being sold in South Africa.

The combination of Afronomics and AfroSolutions, which have been sold in India, is also in the works.

Afroxim will be the Afros’ biggest selling drug.

AfroMedics has also developed AfroHealth, which will offer AfroCare, a product that will treat heart and respiratory problems, and other conditions.

Afrocare will also help to manage diabetes, heart disease and arthritis.

Afracare will be offered by the Afrobampo brand, while a mix-and-match of Afrolax and Afrono are also available.

AfrosMedics and Afrodx, which were launched earlier this year, are both priced at Rs 1,500 and Rs 2,500 respectively.

Afrolabx, a blend product made by AfroTech, will cost Rs 3,000 and Afrolacx, priced at just Rs 2.50, will offer a mixture mix of Afropax and Fenix.

Afrilabx is priced at 2,000, and Afropolax, priced between 2,250 and 2,800, are priced between 1,000 to 1,400.